Freedom Investment Management’s United Therapeutics UTHR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-735	Closed	-$211K	–	684
2025 Q2	$211K	Sell	735 -164	-18%	-$49K	0.02%	694
2025 Q1	$277K	Buy	899 +30	+3%	+$10.3K	0.02%	616
2024 Q4	$307K	Buy	869 +53	+6%	+$19.5K	0.03%	588
2024 Q3	$292K	Buy	816 +3	+0.4%	+$1.01K	0.02%	606
2024 Q2	$259K	Sell	813 -271	-25%	-$71.7K	0.02%	654
2024 Q1	$249K	Sell	1,084 -90	-8%	-$20.3K	0.02%	668
2023 Q4	$258K	Sell	1,174 -100	-8%	-$23K	0.02%	639
2023 Q3	$288K	Sell	1,274 -131	-9%	-$30.2K	0.04%	521
2023 Q2	$310K	Sell	1,405 -333	-19%	-$73.8K	0.03%	533
2023 Q1	$389K	Sell	1,738 -793	-31%	-$195K	0.04%	478
2022 Q4	$704K	Sell	2,531 -163	-6%	-$41.1K	0.08%	320
2022 Q3	$564K	Buy	2,694 +113	+4%	+$25.3K	0.07%	382
2022 Q2	$608K	Sell	2,581 -661	-20%	-$134K	0.06%	380
2022 Q1	$582K	Buy	3,242 +1,341	+71%	+$255K	0.05%	430
2021 Q4	$411K	Sell	1,901 -92	-5%	-$18.1K	0.03%	586
2021 Q3	$368K	Sell	1,993 -1,400	-41%	-$276K	0.03%	591
2021 Q2	$609K	Sell	3,393 -395	-10%	-$75.2K	0.05%	479
2021 Q1	$634K	Sell	3,788 -661	-15%	-$110K	0.05%	445
2020 Q4	$675K	Buy	+4,449	New	+$584K	0.07%	260
2019 Q2	–	Sell	-2,970	Closed	-$349K	–	735
2019 Q1	$349K	Buy	+2,970	New	+$346K	0.03%	473
2018 Q1	–	Sell	-2,875	Closed	-$425K	–	1206
2017 Q4	$425K	Buy	+2,875	New	+$365K	0.02%	706
2016 Q3	–	Sell	-2,394	Closed	-$254K	–	947
2016 Q2	$254K	Buy	+2,394	New	+$267K	0.02%	655